The lowering of the serum PSA levels by aspirin may be mediated through its anti-inflammatory effect, since chronic inflammation causes the development of prostate cancer and anti-inflammatory aspirin has been postulated to have an inhibitory effect on prostate cancer development. The gene discussed is KLK3; the disease is prostate cancer.